CLINICAL_TRIALS
trial_result
· 2021-05-14
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Cancer of the Esophagus [Phase 2]
Summary
Phase 2 trial update on antineoplaston therapy for esophageal adenocarcinoma; study terminated with results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Adenocarcinoma of the Esophagus | Phase 2 | Status: TERMINATED | Results posted: 2021-05-14